By Josh White
Date: Friday 16 Jan 2026
(Sharecast News) - CelLBxHealth said in an update on Friday that it expected to report lower-than-anticipated revenues for 2025 after the deferral of several sales contracts, while highlighting a strong cash position and significant cost reductions as it positions the business for commercial progress in 2026.
By Sharecast
Date: Tuesday 23 Dec 2025
By Sharecast
Date: Friday 19 Dec 2025
| Currency | UK Pounds |
| Share Price | 0.90p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 10.50 |
| 52 Week Low | 0.88 |
| Volume | 3,895,867 |
| Shares Issued | 1,139.40m |
| Market Cap | £10.25m |
| Beta | 0.02 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 17:06 | 193,846 @ 0.90p |
| 16:25 | 63,529 @ 0.94p |
| 16:11 | 1,000,000 @ 0.90p |
| 15:56 | 250,000 @ 0.94p |
| 15:54 | 193,846 @ 0.94p |
You are here: research